Contributing Authors
David S. Cassarino(Kaiser Permanente), Rolf Pfannl(Tufts Medical Center), Vickie Y. Jo(Brigham and Women's Hospital), Roni M. Cox(Cleveland Clinic), Beth Harrison(Brigham and Women's Hospital), Vânia Nosé(Massachusetts General Hospital), Christine J. Ko(Yale University), Rebecca D. Folkerth(Allen Institute for Brain Science), Amitabh Srivastava(Brigham and Women's Hospital), David P. Frishberg(Cedars-Sinai Medical Center), Deborah Dillon(Harvard University), Emily F. Mason(Vanderbilt University Medical Center), Jeffrey F. Krane(University of California, Los Angeles), Matija Snuderl, Matthew R. Lindberg(University of Arkansas for Medical Sciences), Lucian R. Chirieac(Mount Sinai Hospital), Karen Thompson(University of Hawaiʻi at Mānoa), Stefan Kraft, Charles M. Quick(University of Arkansas for Medical Sciences), Lynn D. Cornell(Mayo Clinic), Olga Krasnozhen-Ratush(NYU Langone Health)
Cited by 0
Related Papers
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k